METAGUIDEX_LTD - Accounts


Company registration number 12549905 (England and Wales)
METAGUIDEX LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023
PAGES FOR FILING WITH REGISTRAR
METAGUIDEX LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
4 - 8
METAGUIDEX LTD
BALANCE SHEET
AS AT
30 APRIL 2023
30 April 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Intangible assets
4
212,103
155,947
Tangible assets
5
695
1,291
212,798
157,238
Current assets
Debtors
6
6,643
32,002
Cash at bank and in hand
3,523
27,142
10,166
59,144
Creditors: amounts falling due within one year
7
(16,903)
(11,867)
Net current (liabilities)/assets
(6,737)
47,277
Total assets less current liabilities
206,061
204,515
Creditors: amounts falling due after more than one year
8
(90,000)
(90,000)
Net assets
116,061
114,515
Capital and reserves
Called up share capital
9
100
100
Profit and loss reserves
115,961
114,415
Total equity
116,061
114,515

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

METAGUIDEX LTD
BALANCE SHEET (CONTINUED)
AS AT
30 APRIL 2023
30 April 2023
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 31 August 2023
Dr R Pink
Director
Company Registration No. 12549905
METAGUIDEX LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 APRIL 2023
- 3 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 May 2021
70
-
0
70
Year ended 30 April 2022:
Profit and total comprehensive income for the year
-
114,415
114,415
Issue of share capital
9
30
-
30
Balance at 30 April 2022
100
114,415
114,515
Year ended 30 April 2023:
Profit and total comprehensive income for the year
-
1,546
1,546
Balance at 30 April 2023
100
115,961
116,061
METAGUIDEX LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023
- 4 -
1
Accounting policies
Company information

Metaguidex Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Bioinnovation Hub, Oxford Brookes University, Gipsy Lane, Headington, Oxfordshire, OX3 0BP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Development costs
10 years straight line
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33.3% straight line
1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

METAGUIDEX LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2023
1
Accounting policies
(Continued)
- 5 -
1.7
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and includes cash at bank only.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include other debtors, corporation tax recoverable, and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

METAGUIDEX LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2023
1
Accounting policies
(Continued)
- 6 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of fixed assets.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

METAGUIDEX LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2023
- 7 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
2
3
4
Intangible fixed assets
Development costs
£
Cost
At 1 May 2022
155,947
Additions
56,156
At 30 April 2023
212,103
Amortisation and impairment
At 1 May 2022 and 30 April 2023
-
0
Carrying amount
At 30 April 2023
212,103
At 30 April 2022
155,947
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 May 2022 and 30 April 2023
1,788
Depreciation and impairment
At 1 May 2022
497
Depreciation charged in the year
596
At 30 April 2023
1,093
Carrying amount
At 30 April 2023
695
At 30 April 2022
1,291
METAGUIDEX LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2023
- 8 -
6
Debtors
2023
2022
Amounts falling due within one year:
£
£
Corporation tax recoverable
5,933
13,276
Other debtors
710
18,726
6,643
32,002
7
Creditors: amounts falling due within one year
2023
2022
£
£
Other creditors
16,903
11,867
8
Creditors: amounts falling due after more than one year
2023
2022
£
£
Other creditors
90,000
90,000
9
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 1p each
10,000
10,000
100
100
2023-04-302022-05-01false31 August 2023CCH SoftwareCCH Accounts Production 2023.200No description of principal activityDr R Pink2023-08-31125499052022-05-012023-04-30125499052023-04-30125499052022-04-3012549905core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-04-3012549905core:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-04-3012549905core:OtherPropertyPlantEquipment2023-04-3012549905core:OtherPropertyPlantEquipment2022-04-3012549905core:CurrentFinancialInstrumentscore:WithinOneYear2023-04-3012549905core:CurrentFinancialInstrumentscore:WithinOneYear2022-04-3012549905core:Non-currentFinancialInstrumentscore:AfterOneYear2023-04-3012549905core:Non-currentFinancialInstrumentscore:AfterOneYear2022-04-3012549905core:ShareCapital2023-04-3012549905core:ShareCapital2022-04-3012549905core:RetainedEarningsAccumulatedLosses2023-04-3012549905core:RetainedEarningsAccumulatedLosses2022-04-3012549905core:ShareCapital2021-04-3012549905core:RetainedEarningsAccumulatedLosses2021-04-3012549905bus:Director12022-05-012023-04-3012549905core:RetainedEarningsAccumulatedLosses2021-05-012022-04-30125499052021-05-012022-04-3012549905core:RetainedEarningsAccumulatedLosses2022-05-012023-04-3012549905core:ShareCapital2021-05-012022-04-3012549905core:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-3012549905core:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-05-012023-04-3012549905core:ComputerEquipment2022-05-012023-04-3012549905core:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-04-3012549905core:DevelopmentCostsCapitalisedDevelopmentExpenditurecore:ExternallyAcquiredIntangibleAssets2022-05-012023-04-3012549905core:OtherPropertyPlantEquipment2022-04-3012549905core:OtherPropertyPlantEquipment2022-05-012023-04-3012549905core:CurrentFinancialInstruments2023-04-3012549905core:CurrentFinancialInstruments2022-04-3012549905core:WithinOneYear2023-04-3012549905core:WithinOneYear2022-04-3012549905core:Non-currentFinancialInstruments2023-04-3012549905core:Non-currentFinancialInstruments2022-04-3012549905bus:PrivateLimitedCompanyLtd2022-05-012023-04-3012549905bus:SmallCompaniesRegimeForAccounts2022-05-012023-04-3012549905bus:FRS1022022-05-012023-04-3012549905bus:AuditExemptWithAccountantsReport2022-05-012023-04-3012549905bus:FullAccounts2022-05-012023-04-30xbrli:purexbrli:sharesiso4217:GBP